Search research articles
Contact Us
Filters
Showing results (171-180 of 203) with videos related to
Page
of 21
Sort By:
Journal of the National Cancer Institute
|
December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
Brian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.
Frontiers in Oncology
|
October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Shuchi Gulati, Pedro C Barata, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 Study
Emmanuel S Antonarakis, Qing Cao, Victoria Catharine, et al.
JCO Precision Oncology
|
August 23, 2024
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes
Laura S Graham, Nicholas C Henderson, Olesia Kellezi, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Amanda Broderick, Elizabeth Pan, Jinju Li, et al.
Prostate Cancer and Prostatic Diseases
|
February 22, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration
Zeynep B Zengin, Nicholas C Henderson, Joseph J Park, et al.
The Prostate
|
November 16, 2022
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer
Christopher T Su, Emily Nizialek, Jacob E Berchuck, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
European Urology Oncology
|
February 26, 2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma
Bradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 203) with videos related to
Sort By:
Page
of 21
Journal of the National Cancer Institute
|
December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
Brian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.
Frontiers in Oncology
|
October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
Shuchi Gulati, Pedro C Barata, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2026
Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 Study
Emmanuel S Antonarakis, Qing Cao, Victoria Catharine, et al.
JCO Precision Oncology
|
August 23, 2024
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes
Laura S Graham, Nicholas C Henderson, Olesia Kellezi, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Amanda Broderick, Elizabeth Pan, Jinju Li, et al.
Prostate Cancer and Prostatic Diseases
|
February 22, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration
Zeynep B Zengin, Nicholas C Henderson, Joseph J Park, et al.
The Prostate
|
November 16, 2022
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer
Christopher T Su, Emily Nizialek, Jacob E Berchuck, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
European Urology Oncology
|
February 26, 2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma
Bradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
Page
of 21